NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/23/2024
Back to search
Official data from USPTO
DERMATOGENOMIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DERMATOGENOMIX
ST13
US500000097060095Class
44
Filing
97060095
Registration
7367705
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
04/23/2024
Trademark type
Word
Nice classes
44
Filing date
10/05/2021
Registration date
04/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/23/2024
Last transaction
04/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
2023-05-00
First use in commerce
2023-05-00
Drawing code
4
Owner type
99
Owner location
Auckland, NZ
Examiner
SUTTON, CATHERINE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sharad Paul IP Limited
Representatives
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Advisory services relating to healthadvisory services related to genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
44 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/23/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/21/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/20/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/17/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/17/2024
IUAF
USE AMENDMENT FILED
02/23/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/23/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/14/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/14/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/14/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
11/07/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/02/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/11/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2023
GNRT
NON-FINAL ACTION E-MAILED
02/13/2023
CNRT
NON-FINAL ACTION WRITTEN
02/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/20/2023
ALIE
ASSIGNED TO LIE
01/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2022
GNRT
NON-FINAL ACTION E-MAILED
07/11/2022
CNRT
NON-FINAL ACTION WRITTEN
07/11/2022
DOCK
ASSIGNED TO EXAMINER
07/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/08/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/29/2021
NWAP
NEW APPLICATION ENTERED
10/08/2021
Continuous trademark protection
Get notified about every new filing that threatens DERMATOGENOMIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.